157 research outputs found

    Experimental river delta size set by multiple floods and backwater hydrodynamics

    Get PDF
    River deltas worldwide are currently under threat of drowning and destruction by sea-level rise, subsidence, and oceanic storms, highlighting the need to quantify their growth processes. Deltas are built through construction of sediment lobes, and emerging theories suggest that the size of delta lobes scales with backwater hydrodynamics, but these ideas are difficult to test on natural deltas that evolve slowly. We show results of the first laboratory delta built through successive deposition of lobes that maintain a constant size. We show that the characteristic size of delta lobes emerges because of a preferential avulsion node—the location where the river course periodically and abruptly shifts—that remains fixed spatially relative to the prograding shoreline. The preferential avulsion node in our experiments is a consequence of multiple river floods and Froude-subcritical flows that produce persistent nonuniform flows and a peak in net channel deposition within the backwater zone of the coastal river. In contrast, experimental deltas without multiple floods produce flows with uniform velocities and delta lobes that lack a characteristic size. Results have broad applications to sustainable management of deltas and for decoding their stratigraphic record on Earth and Mars

    Stepwise heating of lunar anorthosites 60025, 60215, 65315 possibly reveals an indigenous noble gas component on the Moon

    Get PDF
    Despite extensive effort during the last four decades, no clear signature of a lunar indigenous noble gas component has been found. In order to further investigate the possible occurrence of indigenous volatiles in the Moon, we have re-analyzed the noble gas and nitrogen isotopic compositions in three anorthosite samples. Lunar anorthosites 60025, 60215 and 65315 have the lowest exposure duration (∌2 Ma) among Apollo samples and consequently contain only limited cosmogenic (e.g. ^(124,126)Xe) and solar wind (SW) noble gases. Furthermore, anorthosites have negligible contributions of fissiogenic Xe isotopes because of their very low Pu and U contents. As observed in previous studies (Lightner and Marti, 1974; Leich and Niemeyer, 1975), lunar anorthosite Xe presents an isotopic composition very close to that of terrestrial atmospheric Xe, previously attributed to “anomalous adsorption” of terrestrial Xe after sample return. The presumed atmospheric Xe contamination can only be removed by heating the samples at medium to high temperatures under vacuum, and is therefore different from common adsorption. To test this hypothesis, we monitored the adsorption of Xe onto lunar anorthositic powder using infrared reflectance spectroscopy. A clear shift in the anorthosite IR absorbance peaks is detected when comparing the IR absorbance spectra of the lunar anorthositic powder before and after exposure to a neutral Xe-rich atmosphere. This observation accounts for the chemical bonding (chemisorption) of Xe onto anorthosite, which is stronger than the common physical bonding (physisorption) and could account for the anomalous adsorption of Xe onto lunar samples. Our high precision Xe isotope analyses show slight mass fractionation patterns across ^(128–136)Xe isotopes with systematic deficits in the heavy Xe isotopes (mostly ^(136)Xe and marginally ^(134)Xe) that have not previously been observed. This composition could be the result of mixing between an irreversibly adsorbed terrestrial contaminant that is mostly released at high temperature and an additional signature. Solar Wind (SW) Xe contents, estimated from SW-Ne and SW-Ar concentrations and SW-Ne/Ar/Xe elemental ratios, do not support SW as the additional contribution. Using a χ^2 test, the latter is best accounted for by cometary Xe as measured in the coma of Comet 67P/Churyumov-Gerasimenko (Marty et al., 2017) or by the primordial U-Xe composition inferred to be the precursor of atmospheric Xe (Pepin, 1994; Avice et al., 2017). It could have been contributed to the lunar budget by volatile-rich bodies that participated to the building of the terrestrial atmosphere inventory (Marty et al., 2017)

    Systematic Dissection of Roles for Chromatin Regulators in a Yeast Stress Response

    Get PDF
    Packaging of eukaryotic genomes into chromatin has wide-ranging effects on gene transcription. Curiously, it is commonly observed that deletion of a global chromatin regulator affects expression of only a limited subset of genes bound to or modified by the regulator in question. However, in many single-gene studies it has become clear that chromatin regulators often do not affect steady-state transcription, but instead are required for normal transcriptional reprogramming by environmental cues. We therefore have systematically investigated the effects of 83 histone mutants, and 119 gene deletion mutants, on induction/repression dynamics of 170 transcripts in response to diamide stress in yeast. Importantly, we find that chromatin regulators play far more pronounced roles during gene induction/repression than they do in steady-state expression. Furthermore, by jointly analyzing the substrates (histone mutants) and enzymes (chromatin modifier deletions) we identify specific interactions between histone modifications and their regulators. Combining these functional results with genome-wide mapping of several histone marks in the same time course, we systematically investigated the correspondence between histone modification occurrence and function. We followed up on one pathway, finding that Set1-dependent H3K4 methylation primarily acts as a gene repressor during multiple stresses, specifically at genes involved in ribosome biosynthesis. Set1-dependent repression of ribosomal genes occurs via distinct pathways for ribosomal protein genes and ribosomal biogenesis genes, which can be separated based on genetic requirements for repression and based on chromatin changes during gene repression. Together, our dynamic studies provide a rich resource for investigating chromatin regulation, and identify a significant role for the “activating” mark H3K4me3 in gene repression

    Lack of PAH emission toward low-mass embedded young stellar objects

    Get PDF
    PAHs have been detected toward molecular clouds and some young stars with disks, but have not yet been associated with embedded young stars. We present a sensitive mid-IR spectroscopic survey of PAH features toward a sample of low-mass embedded YSOs. The aim is to put constraints on the PAH abundance in the embedded phase of star formation using radiative transfer modeling. VLT-ISAAC L-band spectra for 39 sources and Spitzer IRS spectra for 53 sources are presented. Line intensities are compared to recent surveys of Herbig Ae/Be and T Tauri stars. The radiative transfer codes RADMC and RADICAL are used to model the PAH emission from embedded YSOs consisting of a PMS star with a circumstellar disk embedded in an envelope. The dependence of the PAH feature on PAH abundance, stellar radiation field, inclination and the extinction by the surrounding envelope is studied. The 3.3 micron PAH feature is undetected for the majority of the sample (97%), with typical upper limits of 5E-16 W/m^2. Compact 11.2 micron PAH emission is seen directly towards 1 out of the 53 Spitzer Short-High spectra, for a source that is borderline embedded. For all 12 sources with both VLT and Spitzer spectra, no PAH features are detected in either. In total, PAH features are detected toward at most 1 out of 63 (candidate) embedded protostars (<~ 2%), even lower than observed for class II T Tauri stars with disks (11-14%). Assuming typical class I stellar and envelope parameters, the absence of PAHs emission is most likely explained by the absence of emitting carriers through a PAH abundance at least an order of magnitude lower than in molecular clouds but similar to that found in disks. Thus, most PAHs likely enter the protoplanetary disks frozen out in icy layers on dust grains and/or in coagulated form.Comment: 13 pages, 9 figures, accepted for publication in A&

    EBAG9-silencing exerts an immune checkpoint function without aggravating adverse effects

    Get PDF
    Chimeric antigen receptor (CAR) T cells have revolutionized treatment of B-cell malignancies. However, enhancing the efficacy of engineered T cells without compromising their safety is warranted. The estrogen receptor-binding fragment-associated antigen 9 (EBAG9) inhibits release of cytolytic enzymes from cytotoxic T lymphocytes. Here, we examined the potency of EBAG9-silencing for the improvement of adoptive T cell therapy. Micro-RNA-mediated EBAG9 downregulation in transplanted CTLs from immunized mice improved their cytolytic competence in a tumor model. In tolerant female recipient mice that received organ transplants, a minor histocompatibility antigen was turned into a rejection antigen by Ebag9 deletion, indicating an immune checkpoint function for EBAG9. Considerably less EBAG9-silenced human CAR T cells were needed for tumor growth control in a xenotransplantation model. Transcriptome profiling did not reveal additional risks regarding genotoxicity or aberrant differentiation. A single-step retrovirus transduction process links CAR or TCR expression with miRNA-mediated EBAG9 downregulation. Despite higher cytolytic efficacy, release of cytokines associated with cytokine release syndrome remains unaffected. Collectively, EBAG9-silencing enhances effector capacity of TCR- and CAR-engineered T cells, results in improved tumor eradication, facilitates efficient manufacturing, and decreases the therapeutic dose

    Sl-EDGE: Network Slicing at the Edge

    Full text link
    Network slicing of multi-access edge computing (MEC) resources is expected to be a pivotal technology to the success of 5G networks and beyond. The key challenge that sets MEC slicing apart from traditional resource allocation problems is that edge nodes depend on tightly-intertwined and strictly-constrained networking, computation and storage resources. Therefore, instantiating MEC slices without incurring in resource over-provisioning is hardly addressable with existing slicing algorithms. The main innovation of this paper is Sl-EDGE, a unified MEC slicing framework that allows network operators to instantiate heterogeneous slice services (e.g., video streaming, caching, 5G network access) on edge devices. We first describe the architecture and operations of Sl-EDGE, and then show that the problem of optimally instantiating joint network-MEC slices is NP-hard. Thus, we propose near-optimal algorithms that leverage key similarities among edge nodes and resource virtualization to instantiate heterogeneous slices 7.5x faster and within 0.25 of the optimum. We first assess the performance of our algorithms through extensive numerical analysis, and show that Sl-EDGE instantiates slices 6x more efficiently then state-of-the-art MEC slicing algorithms. Furthermore, experimental results on a 24-radio testbed with 9 smartphones demonstrate that Sl-EDGE provides at once highly-efficient slicing of joint LTE connectivity, video streaming over WiFi, and ffmpeg video transcoding

    The Need for Laboratory Measurements and Ab Initio Studies to Aid Understanding of Exoplanetary Atmospheres

    Full text link
    We are now on a clear trajectory for improvements in exoplanet observations that will revolutionize our ability to characterize their atmospheric structure, composition, and circulation, from gas giants to rocky planets. However, exoplanet atmospheric models capable of interpreting the upcoming observations are often limited by insufficiencies in the laboratory and theoretical data that serve as critical inputs to atmospheric physical and chemical tools. Here we provide an up-to-date and condensed description of areas where laboratory and/or ab initio investigations could fill critical gaps in our ability to model exoplanet atmospheric opacities, clouds, and chemistry, building off a larger 2016 white paper, and endorsed by the NAS Exoplanet Science Strategy report. Now is the ideal time for progress in these areas, but this progress requires better access to, understanding of, and training in the production of spectroscopic data as well as a better insight into chemical reaction kinetics both thermal and radiation-induced at a broad range of temperatures. Given that most published efforts have emphasized relatively Earth-like conditions, we can expect significant and enlightening discoveries as emphasis moves to the exotic atmospheres of exoplanets.Comment: Submitted as an Astro2020 Science White Pape

    PAH chemistry and IR emission from circumstellar disks

    Get PDF
    Aims. The chemistry of, and infrared (IR) emission from, polycyclic aromatic hydrocarbons (PAHs) in disks around Herbig Ae/Be and T Tauri stars are investigated. The equilibrium distribution of the PAHs over all accessible charge/hydrogenation states depends on the size and shape of the PAHs and on the physical properties of the star and surrounding disk. Methods. A chemistry model is created to calculate this equilibrium distribution. Destruction of PAHs by ultraviolet (UV) photons, possibly in multi-photon absorption events, is taken into account. The chemistry model is coupled to a radiative transfer code to provide the physical parameters and to combine the PAH emission with the spectral energy distribution (SED) from the star+disk system. Results. Normally hydrogenated PAHs in Herbig Ae/Be disks account for most of the observed PAH emission, with neutral and positively ionized species contributing in roughly equal amounts. Close to the midplane, the PAHs are more strongly hydrogenated and negatively ionized, but these species do not contribute to the overall emission because of the low UV/optical flux deep inside the disk. PAHs of 50 carbon atoms are destroyed out to 100 AU in the disk's surface layer, and the resulting spatial extent of the emission does not agree well with observations. Rather, PAHs of about 100 carbon atoms or more are predicted to cause most of the observed emission. The emission is extended on a scale similar to that of the size of the disk. Furthermore, the emission from T Tauri disks is much weaker and concentrated more towards the central star than that from Herbig Ae/Be disks. Positively ionized PAHs are predicted to be largely absent in T Tauri disks because of the weaker radiation field.Comment: 13 pages, 8 figures, accepted for publication in A&

    Kinetic CRAC uncovers a role for Nab3 in determining gene expression profiles during stress

    Get PDF
    RNA-binding proteins play a key role in shaping gene expression profiles during stress, however, little is known about the dynamic nature of these interactions and how this influences the kinetics of gene expression. To address this, we developed kinetic cross-linking and analysis of cDNAs (\u3c7CRAC), an ultraviolet cross-linking method that enabled us to quantitatively measure the dynamics of protein\u2013RNA interactions in vivo on a minute time-scale. Here, using \u3c7CRAC we measure the global RNA-binding dynamics of the yeast transcription termination factor Nab3 in response to glucose starvation. These measurements reveal rapid changes in protein\u2013RNA interactions within 1\u2009min following stress imposition. Changes in Nab3 binding are largely independent of alterations in transcription rate during the early stages of stress response, indicating orthogonal transcriptional control mechanisms. We also uncover a function for Nab3 in dampening expression of stress-responsive genes. \u3c7CRAC has the potential to greatly enhance our understanding of in vivo dynamics of protein\u2013RNA interactions

    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Get PDF
    Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1ÎČ, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1ÎČ innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.
    • 

    corecore